Systemic Therapy of Disseminated Myeloma in Passively Immunized Mice Using Measles Virus-infected Cell Carriers
Authors:
Open Access
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (6) , 1155-1164
Abstract
No abstract availableKeywords
Funding Information
- Alliance for Cancer Gene Therapy
- National Cancer Institute (CA100634, CA129193, CA129966)
- Mayo Clinic
This publication has 52 references indexed in Scilit:
- The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of SolomonHuman Gene Therapy, 2009
- Intravascularly Administered RGD-Displaying Measles Viruses Bind to and Infect Neovessel Endothelial Cells In VivoMolecular Therapy, 2009
- Tumor‐associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myelomaAmerican Journal of Hematology, 2009
- Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivoNature Protocols, 2009
- Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genomeThe Journal of Gene Medicine, 2009
- Quantitative Molecular Imaging of Viral Therapy for Pancreatic Cancer Using an Engineered Measles Virus Expressing the Sodium-Iodide Symporter Reporter GeneAmerican Journal of Roentgenology, 2009
- A secreted luciferase for ex vivo monitoring of in vivo processesNature Methods, 2008
- A Highly Sensitive Assay for Monitoring the Secretory Pathway and ER StressPLOS ONE, 2007
- Chemokines in multiple myelomaExperimental Hematology, 2006
- Dual Therapy of Ovarian Cancer Using Measles Viruses Expressing Carcinoembryonic Antigen and Sodium Iodide SymporterClinical Cancer Research, 2006